South State Corp Merck & Co., Inc. Transaction History

South State Corp

$1.52 Billion
Q4 2024

A detailed history of South State Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, South State Corp holds 32,550 shares of MRK stock, worth $2.7 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

32,550

Previous 34,044 4.39%

Holding current value

$2.7 Million

Previous $3.87 Million 16.24%

% of portfolio

0.21%

Previous 0.27%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$96.31 - $114.76 $143,887 - $171,451	-1,494 Reduced 4.39%	32,550 $3.24 Million
Q3 2024 Nov 08, 2024	SELL	$111.15 - $128.97 $10,559 - $12,252	-95 Reduced 0.28%	34,044 $3.87 Million
Q2 2024 Aug 02, 2024	SELL	$123.8 - $132.96 $57,814 - $62,092	-467 Reduced 1.35%	34,139 $4.23 Million
Q1 2024 May 06, 2024	BUY	$113.24 - $131.95 $14,041 - $16,361	124 Added 0.36%	34,606 $4.57 Million
Q4 2023 Feb 06, 2024	SELL	$100.18 - $109.02 $130,634 - $142,162	-1,304 Reduced 3.64%	34,482 $3.76 Million
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $27,178 - $30,183	-264 Reduced 0.73%	35,786 $3.68 Million
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $75,266 - $82,037	693 Added 1.96%	36,050 $4.16 Million
Q1 2023 May 08, 2023	BUY	$102.94 - $114.86 $10,705 - $11,945	104 Added 0.3%	35,357 $3.76 Million
Q4 2022 Feb 10, 2023	BUY	$87.44 - $112.11 $54,125 - $69,396	619 Added 1.79%	35,253 $3.91 Million
Q3 2022 Nov 07, 2022	BUY	$84.53 - $94.96 $36,855 - $41,402	436 Added 1.27%	34,634 $2.98 Million
Q2 2022 Aug 05, 2022	BUY	$83.49 - $94.64 $435,567 - $493,736	5,217 Added 18.0%	34,198 $3.12 Million
Q1 2022 May 06, 2022	BUY	$73.51 - $82.4 $124,158 - $139,173	1,689 Added 6.19%	28,981 $2.38 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $1,734 - $2,172	24 Added 0.09%	27,292 $2.09 Million
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $116,049 - $127,625	-1,619 Reduced 5.6%	27,268 $2.05 Million
Q2 2021 Aug 10, 2021	SELL	$70.31 - $77.77 $124,940 - $138,197	-1,777 Reduced 5.8%	28,887 $2.25 Million
Q1 2021 May 12, 2021	SELL	$68.86 - $81.11 $211,193 - $248,764	-3,067 Reduced 9.09%	30,664 $2.36 Million
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $34,736 - $38,550	-484 Reduced 1.41%	33,731 $2.63 Million
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $114,526 - $129,816	1,565 Added 4.79%	34,215 $2.84 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $23,379 - $26,603	332 Added 1.03%	32,650 $2.53 Million
Q1 2020 May 04, 2020	SELL	$63.36 - $87.82 $176,964 - $245,281	-2,793 Reduced 7.95%	32,318 $2.49 Million
Q4 2019 Feb 05, 2020	SELL	$77.58 - $87.54 $99,069 - $111,788	-1,277 Reduced 3.51%	35,111 $3.19 Million
Q3 2019 Nov 08, 2019	SELL	$76.08 - $82.93 $202,753 - $221,008	-2,665 Reduced 6.82%	36,388 $3.06 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $461,432 - $539,065	-6,607 Reduced 14.47%	39,053 $3.27 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $4,174 - $4,761	60 Added 0.13%	45,660 $3.8 Million
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $72,677 - $84,340	1,114 Added 2.5%	45,600 $3.48 Million
Q3 2018 Nov 08, 2018	SELL	$57.69 - $67.84 $294,045 - $345,780	-5,097 Reduced 10.28%	44,486 $3.16 Million
Q2 2018 Aug 03, 2018	SELL	$50.83 - $59.72 $86,665 - $101,822	-1,705 Reduced 3.32%	49,583 $3.01 Million
Q1 2018 May 11, 2018	SELL	$50.96 - $59.23 $117,360 - $136,406	-2,303 Reduced 4.3%	51,288 $2.79 Million
Q4 2017 Feb 12, 2018	BUY	$51.62 - $61.64 $203,692 - $243,231	3,946 Added 7.95%	53,591 $3.02 Million
Q3 2017 Nov 09, 2017	SELL	$58.67 - $63.13 $43,474 - $46,779	-741 Reduced 1.47%	49,645 $3.18 Million
Q2 2017 Aug 10, 2017	BUY	N/A	50,386	50,386 $3.23 Million

Others Institutions Holding MRK

# of Institutions

3,946

Shares Held

1.94B

Call Options Held

16.1M

Put Options Held

15.1M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $210B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.

Account